Menu

Nonhuman Primate Model of Zika

Researchers infect rhesus macaques with the virus to better study its effects in humans.

Jun 28, 2016
Tanya Lewis

Rhesus macaquesWIKIMEDIA, ARINDAM ADITYAScientists have developed a nonhuman primate model of Zika virus infection to better understand its course in humans, especially in pregnant women. David O’Connor of the University of Wisconsin-Madison and colleagues injected eight rhesus macaques—two of them pregnant—with the Asian strain of the virus currently circulating in South and Central America. The non-pregnant and pregnant monkeys were still infected 21 days and up to 57 days later, respectively, and all animals were immune to reinfection 10 weeks post-injection, the researchers reported today (June 28) in Nature Communications. Prior to publication, the team was posting its data online in real time.

“This study in a nonhuman primate provides an important contribution to our understanding of the course of Zika virus infection in primates,” Amelia Pinto of Saint Louis University, Missouri, who was not involved in the work, said in a statement sent to reporters. However, “this study is ongoing, so from the results reported in this paper we cannot yet say that macaques are going to be a good model for understanding the links between Zika infection during pregnancy and the increased risk for microcephaly,” Pinto added.

In previous, unpublished work, O’Connor and colleagues infected two pregnant macaques with Zika during the animals’ third trimesters, sacrificed the fetuses at full term, and performed necropsies on them. The team did not observe evidence of microcephaly in the baby monkeys, but is still analyzing the aborted animals’ tissues. For the present study, the researchers infected pregnant monkeys during their first trimesters of pregnancy, as well as non-pregnant rhesus macaques (three males and three females).

With monkeys, “you can do experiments much more comprehensively than only with imaging in humans,” O’Connor said yesterday (June 27) during a press briefing.

The team detected the virus in the animals’ blood, urine, and saliva for up to 17 days post-injection. The virus was also found, for less than a week, in cerebrospinal fluid and vaginal fluid, the researchers wrote. None of the infected monkeys showed symptoms of Zika infection.

It’s unclear why the pregnant monkeys remained infected for longer than the non-pregnant ones. “Our leading hypothesis is it indicates the fetus is infected and is shedding virus back into mother’s bloodstream,” O’Connor told reporters during the briefing.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.